3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Sarcoma
1
Head & Neck
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Dermatologic
1
Breast
1
Conditions
Lymphoma
45
Breast Neoplasms
44
Precursor Cell Lymphoblastic Leukemia-Lymphoma
42
Lymphoma, Large B-Cell, Diffuse
41
Lymphoma, Non-Hodgkin
39
Multiple Myeloma
35
Leukemia
34
Melanoma
32
Leukemia, Lymphocytic, Chronic, B-Cell
32
Recurrence
31
Leukemia, Myeloid, Acute
28
Lymphoma, Follicular
27
Lymphoma, B-Cell
25
Ovarian Neoplasms
24
Lymphoma, Mantle-Cell
23
Neoplasm Metastasis
22
Hematologic Neoplasms
19
Pancreatic Neoplasms
18
Myelodysplastic Syndromes
18
Hodgkin Disease
18
Burkitt Lymphoma
16
Neoplasms
13
Carcinoma, Non-Small-Cell Lung
13
Triple Negative Breast Neoplasms
12
Lymphoma, B-Cell, Marginal Zone
12
Colorectal Neoplasms
12
Stomach Neoplasms
11
Waldenstrom Macroglobulinemia
9
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
9
Carcinoma, Hepatocellular
9
Interventions
sargramostim
1
rebastinib
1
pembrolizumab
1
X-Rays
1
Specimen Handling
1
Paclitaxel
1
Magnetic Resonance Spectroscopy
1
Immunoglobulin G
1
DCC-2036
1
Cyclophosphamide
1
Colony-Stimulating Factors
1
Biopsy
1
Axitinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1/2
×
Carcinosarcoma
×
Cyclophosphamide
×
Clear all
NCT05269381
2026-03-12
PNeoVCA
Mayo Clinic
Phase 1/2
Recruiting
132 enrolled